Aquestive Therapeutics Inc (AQST)
SG&A Expenses
$14.06M
Quarterly · Period ending: · USD
AQST SG&A Expenses
Latest reported$14.06Mperiod ending
Latest reported$14.06Mperiod ending
AQST Quarterly SG&A Expenses ($6.13M → $14.06M)
Quarterly SG&A Expenses
High-resolution chart · PNG
AQST sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 14,063,000 | |
| 10,977,000 | |
| 32,822,000 | |
| 15,250,000 | |
| 12,705,000 | |
| 19,072,000 | |
| 16,009,000 | |
| 12,126,000 | |
| 11,356,000 | |
| 10,689,000 | |
| 9,550,000 | |
| 7,385,000 | |
| 7,360,000 | |
| 7,455,000 | |
| 11,812,000 | |
| 12,459,000 | |
| 15,587,000 | |
| 13,021,000 | |
| 14,981,000 | |
| 12,129,000 | |
| 13,134,000 | |
| 13,231,000 | |
| 15,582,000 | |
| 11,803,000 | |
| 13,894,000 | |
| 14,613,000 | |
| 16,474,000 | |
| 13,714,000 | |
| 16,246,000 | |
| 17,908,000 | |
| 18,703,000 | |
| 12,345,000 | |
| 33,647,000 | |
| 7,569,000 | |
| 7,565,000 | |
| 6,161,000 | |
| 5,223,000 | |
| 6,128,000 |